CRESCENT BIOPHARMA, INC. (CBIO) › EPS (Diluted)CRESCENT BIOPHARMA, INC. (CBIO) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2012: $0.332013: $-8.872014: $-0.602019: $-1.342020: $-1.122021: $-1.232022: $-0.892023: $-0.582024: $-0.59$-0.592012EPS (Diluted) (USD/shares)2024Fiscal YearEPS (Diluted)Change YoY2024$-0.59-1.7%2023$-0.58+34.8%2022$-0.89+27.6%2021$-1.23-9.8%2020$-1.12+16.4%2019$-1.34—2014$-0.60+93.2%2013$-8.87-2787.9%2012$0.33—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share